期刊文献+

SPG膜乳化法制备粒径均一可控的载蛋白缓释微球 被引量:2

Preparation of protein loaded microspheres with uniform and controllable particle sizes by SPG membrane emulsification
原文传递
导出
摘要 目的:研究一种制备粒径均一可控的载蛋白缓释微球的新工艺,探究微球粒径、载体材料、形态结构与微球载药释药性能的关系。方法:以牛血清白蛋白(BSA)为模型药物,PLGA和PEG-PLGA作为载体材料,采用SPG膜乳化法,通过调整不同孔径(3,5,7,12μm)的SPG膜制备不同粒径的微球。考察微球粒径、包封率、释放行为、表面/内部形态等性质,并对微球微观结构相关的参数如孔径、平面孔隙率等进行定量分析。结果:微球的粒径与SPG膜孔径呈正相关关系,且相关系数>0.9。随着微球粒径的增大,载药量和包封率也呈现增大的趋势,突释减轻。PLGA和PEG-PLGA微球的内部结构随微球粒径增加的变化差异较大。结论:获得较为满意的制备载蛋白微球的新工艺,微球形态圆整,粒径均一可控。 OBJECTIVE To prepare protein sustained release microspheres with uniform and controllable particle sizes by a new method, then explore the relationship between microspheres particle size, carrier materials, morphological structure and the drug release characteristics. METHODS SPG membranes with different apertures (3,5,7,12μm) were chosen to prepare sustain released microspheres of different particle sizes by SPG membrane emulsification. Bovine serum albumin (BSA) was used as the model drug and PLGA/PEG-PLGA as the carrier material. The particle size, entrapment efficiency, release behavior and surface/internal morphology were investigated, and the microstructures related parameters such as pore size and plane porosity were quantitatively analyzed. RESULTS The particle size of microspheres was positively correlated with the pore size of SPG membrane, and the correlation coefficient was 〉0. 9. With the increase of particle size, the drug loading and entrapment efficiencies also showed increasing trends, and the burst release was decreased. The internal structures of PLGA and PEG-PLGA microspheres varied greatly with increase of microsphere particle size. CONCLUSION This new method can prepare protein loaded microsphere with rounded surface and more uniform particle size.
出处 《中国医院药学杂志》 CAS 北大核心 2017年第10期911-915,共5页 Chinese Journal of Hospital Pharmacy
关键词 SPG膜乳化法 PEG-PLGA PLGA 缓释微球 SPG membrane emulsification PEG-PLGA PLGA sustain released microspheres
  • 相关文献

参考文献2

二级参考文献22

  • 1陈丹,赵洁.适合于植物花器官的冰冻切片技术[J].武汉植物学研究,2005,23(3):285-290. 被引量:37
  • 2YANG Yiyan, CHUNG Taishung, NG Ngeeping.Morphology, drug distribution, and in vitro release profile of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method [ J ]. Biomaterials ,2001,22(3) :231-241.
  • 3KLOSE D, SIEPMANN F, ELKHARRAZ K, et al. How porosity and size affect the drug release mechanisms from PLGA-based micropartieles [ J ]. Int J Pharm, 2006, 314 (2) :198-206.
  • 4LEE J, OH Y J, LEE S K, et al. Facile control of porous structures of polymer microspheres using an osmotic agent for pulmonary delivery [ J ]. J Control Release, 2010, 146 (1) :61-67.
  • 5Felix Lanao R P, LEEUWENBURGH S C G,WOLKE J G C, et al. In vitro degradation rate of apatitic calcium phosphate cement with incorporated PLGA microspheres [ J] .Aeta Biomater,2011,7(9) :3459-3468.
  • 6CHENG Delin, GAO Huiehang, HAO Lijing, et al. Facile development of a hollow composite microsphere with porous surface for cell delivery [ J ] .Mat Lett, 2013,111 ( 15 ) : 238- 241.
  • 7DELPLACE C, THILLAYE du B O, SIEPMANN F, et al. PLGAs bearing carboxylated side chains: novel matrix formers with improved properties for controlled drug delivery[ J] .J Control Release ,2013,166(3) :256-267.
  • 8ANDERSON J M,SHIVE M S. Biodegradation and biocom- patibility of PLA and PLGA microspheres [ J ]. Adv Drug Deliv Rev,2012,64(Suppl) :72-82.
  • 9QI Feng, WU Jie, YANG Tingyuan, et al. Mechanistic studies for monodisperse exenatide-loaded PLGA microspheres prepared by different methods based on SPG membrane emulsification [ J 1. Acta Biomater, 2014,10 ( 8 ) : 4247-4256.
  • 10KLOSE D, SIEPMANN F,WILLART J F, et al. Drug release from PLGA-based microparticles : effects of the microparticle : bulk fluid ratio[J]. Int J Pharm,2010,383(1/2) :123-131.

共引文献10

同被引文献26

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部